For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
LVEDHDGVSVVSVSGEIDLVTAPALEQAIGAVVADSPPALVIDLSAVEFLGSVGLKILAATYEKLGKETG FGVVARGPATRRPIHLTGLDKTFPLYPTLDDALTAVRDGKLNG
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. avium 104 | MAV_0435 | - | - | 100% (113) | anti-anti-sigma factor |
| M. avium 104 | MAV_5272 | - | 1e-21 | 46.53% (101) | anti-anti-sigma factor |
| M. avium 104 | MAV_1619 | - | 2e-05 | 34.67% (75) | anti-anti-sigma factor |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb3712c | - | 2e-28 | 75.00% (80) | hypothetical protein Mb3712c |
| M. gilvum PYR-GCK | Mflv_2021 | - | 6e-22 | 47.96% (98) | anti-sigma-factor antagonist |
| M. tuberculosis H37Rv | Rv3687c | rsfB | 6e-41 | 72.97% (111) | anti-anti-sigma factor RSFB (anti-sigma factor antagonist) |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | - | - | - | - | - |
| M. marinum M | MMAR_5181 | - | 3e-50 | 85.71% (112) | anti-anti-sigma regulatory factor |
| M. smegmatis MC2 155 | MSMEG_6127 | - | 4e-21 | 45.00% (100) | anti-anti-sigma factor |
| M. thermoresistible (build 8) | TH_1832 | - | 6e-29 | 56.88% (109) | ANTI-ANTI-SIGMA FACTOR RSFB (ANTI-SIGMA FACTOR ANTAGONIST) |
| M. ulcerans Agy99 | MUL_3602 | - | 5e-08 | 34.91% (106) | anti sigma factor antagonist |
| M. vanbaalenii PYR-1 | Mvan_3003 | - | 3e-21 | 46.39% (97) | anti-sigma-factor antagonist |
CLUSTAL 2.0.9 multiple sequence alignment
MAV_0435|M.avium_104 --------------------MVEDH--DGVSVVSVSGEIDLVTAPALEQA
MMAR_5181|M.marinum_M -----------MSAPDSITAVVTDH--DGVTVLSIGGEIDLVTAPALEEA
Mb3712c|M.bovis_AF2122/97 --------------------------------------------------
Rv3687c|M.tuberculosis_H37Rv -----------MSAPDSITVTVADH--NGVAVLSIGGEIDLITAAALEEA
TH_1832|M.thermoresistible__bu ---------------------VEHR--DDSAVLRVQGVVDLATGDALQQA
MSMEG_6127|M.smegmatis_MC2_155 MTSQ-----------DPANCTVEERRVGDITVVAVTGTVDMLTAPKLEDA
Mvan_3003|M.vanbaalenii_PYR-1 MDEQAAEGTNVGGAASSSTCVVTERWVERTAVVAVSGVVDMLTSPQLESA
Mflv_2021|M.gilvum_PYR-GCK ------------------MQQFTEREVDGVVIVAAVGAIDMLTAPQLQEA
MUL_3602|M.ulcerans_Agy99 ----------------MDLLAVEHEVRQDTVVVRAKGDVDSSTVEQLVVH
MAV_0435|M.avium_104 IGAVVADSPPA----LVIDLSAVEFLGSVGLKILAATYEK-LGKETGFGV
MMAR_5181|M.marinum_M IGAVVADSPTA----LVIDLSGVEFLGSVGLKILAATYEK-LGTAAEFGV
Mb3712c|M.bovis_AF2122/97 ----MADNPTA----LVIDLSAVEFLGSVGLKILAATSEK-IGQSVKFGV
Rv3687c|M.tuberculosis_H37Rv IGEVVADNPTA----LVIDLSAVEFLGSVGLKILAATSEK-IGQSVKFGV
TH_1832|M.thermoresistible__bu IDDLIATRPSA----LVVDLSAVDFLASVGLQILVATHER-LSPSARFAV
MSMEG_6127|M.smegmatis_MC2_155 IGSAAKSEPSA----VVVDLSAVDFLASAGMGVLVAAHGE-LAPAVRLVV
Mvan_3003|M.vanbaalenii_PYR-1 IDTALSQQPAA----VVIDFTDVEFLASAGMGVLVAAHDK-AGSDVKISV
Mflv_2021|M.gilvum_PYR-GCK VAAAARRRPSG----LVVDLTSVDFLGSAGMQVLMETRKG-LDGDTRFAV
MUL_3602|M.ulcerans_Agy99 LAAAMQLAATHPARLVVIDLQPVTFFGSAGLNAVLECHEQGMAAGTSVRL
.. :*:*: * *:.*.*: : . . :
MAV_0435|M.avium_104 VARGPATRRPIHLTGLDKTFPLYPTLDDALTAVRDGKLNG-------
MMAR_5181|M.marinum_M VAQGPATRRPIHLTGLDKTFPLYPALDDALTGVRDGKLNR-------
Mb3712c|M.bovis_AF2122/97 VARGSVTRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR-------
Rv3687c|M.tuberculosis_H37Rv VARGSVTRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR-------
TH_1832|M.thermoresistible__bu VADGPATSRPIQLTRLDEVIALYPTLDEALSGVRTGERAE-------
MSMEG_6127|M.smegmatis_MC2_155 VADGPATSRPLKLVGIADVVDLFATLDEALSSLKT------------
Mvan_3003|M.vanbaalenii_PYR-1 VAEGPATSRPLKLVGIADIVALYPNLEEALAARDT------------
Mflv_2021|M.gilvum_PYR-GCK VADGPATSRPLKITGITDYVDLYPSLDVALADLAG------------
MUL_3602|M.ulcerans_Agy99 VADHGQLLAPIQVTELDRIFEIYPTLAGALRPGKPGEHDLEDVERPR
** *::: : . ::. * **